In designing regulations, governments are expected to balance the risks and benefits of GMOs in the public interest and determine whether biotechnology addresses the development needs of their country. However, increasingly, they are faced with global pressures upon the scope, depth and enforcement of their biosafety regulations. There is a real danger that in the push to accommodate trade concerns and the demands of exporters of GMOs, countries are losing an important opportunity to define for themselves whether and in what way biotechnology may assist their development.
Democratising Biotechnology: Genetically Modified Crops in Developing Countries Briefing Series, Briefing 7. Brighton, UK: IDS. 2 pp.